scispace - formally typeset
M

Mary Motyl

Researcher at Merck & Co.

Publications -  106
Citations -  4437

Mary Motyl is an academic researcher from Merck & Co.. The author has contributed to research in topics: Imipenem & Pseudomonas aeruginosa. The author has an hindex of 28, co-authored 85 publications receiving 3627 citations.

Papers
More filters
Journal ArticleDOI

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.

TL;DR: Platencin shows potent in vivo efficacy without any observed toxicity, emphasizing the fact that more antibiotics with novel structures and new modes of action can be discovered by using this antisense differential sensitivity whole-cell screening paradigm.
Journal ArticleDOI

Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

TL;DR: The minimal effective concentration end point, defined as the lowest caspofungin concentration yielding conspicuously aberrant hyphal growth, gave excellent reproducibility for data from 14 of the 17 participating laboratories, and the best interlaboratory separation of Candida isolates of known high and low susceptibility to casp ofungin.